Trials / Completed
CompletedNCT02175719
Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Investigation of the clinical condition in patients with cervical dystonia by Toronto Western Spasmodic Torticollis Scale (TWSTRS)
Conditions
Timeline
- Start date
- 2013-04-16
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2014-06-26
- Last updated
- 2018-07-11
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02175719. Inclusion in this directory is not an endorsement.